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Introduction
Preterm birth affects approximately 15 million infants annually and is the most common cause of  death in chil-
dren under 5 years of  age (1, 2). Preterm neonates are at high risk of  complications, including ongoing neuro-
logical and developmental disabilities (3, 4). The majority of  preterm births are spontaneous (65%–70%), and 
the remainder (30%–35%) are iatrogenic (5–7). Spontaneous preterm births are preceded by preterm labor (5, 
8, 9). The pathophysiological mechanisms that lead to preterm labor and the factors that confer susceptibility 
or resilience must be defined in order to identify effective strategies to prevent preterm birth.
Preterm labor is a syndrome of  multiple etiologies (6), but a large subset of  spontaneous preterm births is 
triggered by infectious or sterile insults that converge on immune and inflammatory mechanisms. Proinflam-
matory mediators convert the uterus from a quiescent to contractile state (10–13) and exert fetal inflammatory 
injury that exacerbates the neonatal consequences of  prematurity (14, 15). In preterm labor, macrophages are 
conventionally thought to promote pathology by exerting proinflammatory functions that stimulate uterine 
contractility and cervical ripening (16–18). Macrophages with a proinflammatory phenotype are enriched in 
Macrophages are commonly thought to contribute to the pathophysiology of preterm labor 
by amplifying inflammation — but a protective role has not previously been considered to our 
knowledge. We hypothesized that given their antiinflammatory capability in early pregnancy, 
macrophages exert essential roles in maintenance of late gestation and that insufficient 
macrophages may predispose individuals to spontaneous preterm labor and adverse neonatal 
outcomes. Here, we showed that women with spontaneous preterm birth had reduced 
CD209+CD206+ expression in alternatively activated CD45+CD14+ICAM3– macrophages and increased 
TNF expression in proinflammatory CD45+CD14+CD80+HLA-DR+ macrophages in the uterine 
decidua at the materno-fetal interface. In Cd11bDTR/DTR mice, depletion of maternal CD11b+ myeloid 
cells caused preterm birth, neonatal death, and postnatal growth impairment, accompanied by 
uterine cytokine and leukocyte changes indicative of a proinflammatory response, while adoptive 
transfer of WT macrophages prevented preterm birth and partially rescued neonatal loss. In a 
model of intra-amniotic inflammation–induced preterm birth, macrophages polarized in vitro 
to an M2 phenotype showed superior capacity over nonpolarized macrophages to reduce uterine 
and fetal inflammation, prevent preterm birth, and improve neonatal survival. We conclude that 
macrophages exert a critical homeostatic regulatory role in late gestation and are implicated as a 
determinant of susceptibility to spontaneous preterm birth and fetal inflammatory injury.
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the uterine decidua of  women who undergo spontaneous preterm labor (16, 19) and in the uterus and cervix 
of  rodents administered proinflammatory stimuli to model preterm birth (20–22). Elevated proinflammatory 
cytokines, notably IL-6, IL-1β, and TNF, are detected prior to preterm birth in the uterus, placenta, amni-
otic fluid, and fetal tissues, and macrophages are implicated as a primary source and target population of  
these factors (20, 23–25). Macrophages also produce matrix metalloproteinases thought to assist in cervical 
ripening and rupture of  the fetal membranes (26), and the kinetics of  their recruitment are consistent with 
postpartum tissue remodeling and repair (22, 23). Nevertheless, animal experiments designed to investigate 
actions of  proinflammatory macrophages in the progression of  labor have not provided definitive evidence of  
a rate-limiting role for macrophages in labor initiation (27, 28).
Increasingly, macrophages are understood to exert not only immune-regulatory roles but also trophic 
and remodeling roles that facilitate development and maintain homeostasis in a wide range of  peripheral 
tissues (29, 30). Earlier in pregnancy, uterine macrophage populations with alternatively activated, homeo-
static phenotypes are involved in embryo implantation and placental development and defense against 
placental infection in mice (31–33) and humans (34–37).
We proposed that in late gestation, uterine macrophages may exert not only proinflammatory actions 
but also antiinflammatory homeostatic effects to sustain gestation prior to labor initiation at term. In the 
current study, we hypothesized that macrophages have essential roles in maintenance of  late-gestation preg-
nancy, and that insufficient macrophages may predispose individuals to spontaneous preterm labor and 
adverse neonatal outcomes. To test this hypothesis, we undertook a series of  experiments including 1) 
immunophenotyping of  decidual macrophages from women with either term or spontaneous preterm birth, 
2) targeted depletion of  CD11b+ macrophages in Cd11bDTR/DTR transgenic mice, and 3) adoptive transfer of  
in vitro M2-polarized macrophages into mice administered intra-amniotic LPS to induce preterm birth. 
The results demonstrated a hitherto unappreciated homeostatic role for macrophages in late gestation, 
exerted by suppression of  proinflammatory cytokines to maintain uterine quiescence, sustain pregnancy, 
and protect the fetus from premature birth and inflammatory injury that compromise normal development 
and postnatal survival.
Results
Altered macrophage phenotypes at the materno-fetal interface in women with spontaneous preterm birth. Decidual 
macrophages with homeostatic properties are present in the uterus in early (35) and late (19) pregnancy and 
have the potential to contribute to the immune environment that sustains pregnancy tolerance to on-time 
birth (19, 35–38). We used flow cytometry to investigate the phenotypes of  macrophages in uterine decid-
ual tissues (Figure 1A) at the time of  delivery in n = 69 women with a term birth (mean gestational age at 
delivery = 39.1 weeks) and n = 29 women with a spontaneous preterm birth (mean gestational age at deliv-
ery = 35.1 weeks). Women were matched for age, BMI, race, and delivery mode (Table 1). Most women 
included in this study were African American, a high-risk population for preterm birth (39).
Several macrophage subpopulations were identified in both the decidua basalis and the decidua 
parietalis (Supplemental Figure 1, A and B; supplemental material available online with this article; 
https://doi.org/10.1172/jci.insight.146089DS1). Macrophages with a proinflammatory phenotype 
(CD45+CD14+CD80+HLA-DR+ cells; refs. 19, 40, 41) and macrophages with an alternatively activat-
ed/homeostatic phenotype (CD45+CD14+ICAM3– cells; ref. 35) (Figure 1, B and C) both exhibited 
different phenotypic features in women with spontaneous preterm birth than in those who delivered at 
term (Figure 1, D and E). Notably, macrophages with a proinflammatory phenotype more commonly 
expressed TNF in both the decidua basalis and the decidua parietalis of  women with spontaneous 
preterm birth (Figure 1F). Among macrophages expressing the CD45+CD14+ICAM3– alternatively acti-
vated phenotype, fewer expressed activation markers CD206+CD209+, again in both tissue compart-
ments (Figure 1G). No changes were apparent in the relative proportions of  the parent CD45+CD14+C-
D80+HLA-DR+ and CD45+CD14+ICAM3– macrophage populations (Supplemental Figure 2, A and B); 
or proinflammatory macrophages expressing iNOS or IL-12; or homeostatic macrophages expressing 
CD163, IL-10, or NRP-1 (Supplemental Figure 2, C and D). Furthermore, in a third group of  women 
with preterm birth due to iatrogenic causes (n = 11, Supplemental Table 1), analysis of  decidual mac-
rophages showed no change in TNF expression in CD45+CD14+CD80+HLA-DR+ cells (Supplemental 
Figure 3A). Although the frequency of  CD45+CD14+ICAM3–CD206+CD209+ cells was reduced in the 
decidua basalis compared with term tissues (Supplemental Figure 3B), this change was not evident in 
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the larger decidua parietalis compartment. These findings indicate a specific change in the activation 
status of  decidual macrophages in women who underwent spontaneous preterm birth, with a shift away 
from a homeostatic and toward a proinflammatory state. This finding prompted us to explore the phys-
iological requirement for macrophages in late gestation using an in vivo model.
CD11b+ macrophage depletion in late gestation causes preterm birth and adverse neonatal outcomes. To inves-
tigate the effects of  macrophage depletion in late gestation, we used Cd11bDTR/DTR transgenic mice to 
allow acute, transient depletion of  CD11b+ macrophages upon administration of  diphtheria toxin (DT) 
(42, 43). Cd11bDTR/DTR mice and control WT Cd11bWT/WT mice were mated with BALB/c males to achieve 
allogeneic pregnancy, and then administered DT or PBS (vehicle control) on 16 dpc (3 days prior to 
expected birth, approximately equivalent to 34 weeks’ gestation in humans), and pregnancy and neo-
natal outcomes were assessed (Figure 2A). Administration of  DT on 16 dpc resulted in preterm birth 
(delivery of  pups within 48 hours of  DT administration) in 75% of  CD11bDTR/DTR dams but did not 
affect timing of  birth in CD11bWT/WT dams (Figure 2, B and C), consistent with a mechanism involving 
CD11b+ cell depletion. Control CD11bWT/WT dams given DT and Cd11bDTR/DTR dams given PBS all deliv-
ered on time at term (Figure 2C).
The viability and health of  pups born to CD11bDTR/DTR mice given DT were severely affected, but pups of  
CD11bWT/WT mice given DT were healthy. CD11bDTR/DTR and CD11bWT/WT dams given DT and CD11bDTR/DTR 
dams given PBS all delivered a similar number of  pups (data not shown), but in CD11bDTR/DTR mice given 
DT, 74% of  pups were either born dead or failed to survive the first 24 hours compared with control groups, 
for which postnatal survival was 100% (Figure 2D). Perinatal loss is a common feature of  mouse preterm 
birth models (44, 45) and is likely attributable to the developmental immaturity of  pups born before 18 dpc, 
as well as exposure to maternal inflammatory mediators that cause placental and/or fetal inflammatory 
injury (15). Surviving pups from 2 CD11bDTR/DTR mice given DT that delivered after 18 dpc showed impaired 
growth in the early postnatal phase compared with controls (Figure 2, E and F), although this was partially 
normalized by 21 days of  age (Figure 2G).
Maternal DT administration later in gestation (at 17 dpc) also shortened gestational length (Sup-
plemental Figure 4A) and decreased neonatal survival (Supplemental Figure 4B), but not to the same 
extent as depletion at 16 dpc, potentially because fetuses were more developmentally mature at this time. 
Moreover, DT administration on 17 dpc caused reduced birth weight followed by catch-up growth in the 
postnatal phase (Supplemental Figure 4, C–E). These data suggest that CD11b+ macrophages may be 
essential for sustaining late gestation and ensuring optimal fetal development, neonatal survival, and a 
normal postnatal growth trajectory.
Table 1. Demographic and clinical characteristics of the study population
Parameter Term birth Spontaneous preterm birth P value
Number of women (n) 69 29
Maternal age 
 [years; median (IQR)]A
24 (21–29) 23 (22–30) 0.81
Body mass index 
 [kg/m2; median (IQR)]A
28.3 (24.6–33.8) 27.3 (21.6–29.7)B 0.14
Gestational age at delivery 
 [weeks; median (IQR)]A
39.1 (38.6–40.1) 35.1 (33–36.1) <0.001
Birth weight 
 [grams; median (IQR)]A
3200 (2885–3560) 2120 (1940–2455) <0.001
Race and ethnicityC 0.52
 African American 85.5% (59/69) 79.3% (23/29)
 White 5.8% (4/69) 3.4% (1/29)
 Hispanic 2.9% (2/69) 3.4% (1/29)
 Asian 2.9% (2/69) 6.9% (2/29)
 Not provided 2.9% (2/69) 6.9% (2/29)
PrimiparityC 18.8% (13/69) 13.8% (4/29) 0.77
Cesarean deliveryC 29% (20/69) 20.7% (6/29) 0.46
AMann-Whitney U test. BSix missing data points. CFisher’s exact test.
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Figure 1. Specific subsets of proinflammatory and homeostatic macrophage subsets are differentially abundant at the materno-fetal interface 
of women with spontaneous preterm birth compared with term birth. (A) Schematic representation of the materno-fetal interface, including the 
uterine decidua basalis and decidua parietalis. Cell suspensions were prepared from the decidual tissues, and macrophage subsets were analyzed 
by flow cytometry with markers CD14, CD80, HLA-DR, ICAM3, CD206, CD209, CD163, NRP-1, TNF, IL12, iNOS, and IL10, according to the gating 
strategy in Supplemental Figure 1. (B) Representative FACS plots of CD45+CD14+CD80+HLA-DR+ cells, considered proinflammatory macrophages, 
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Maternal macrophages, but not fetal macrophages, are implicated in preterm birth. Next, we investigated the 
specific lineages of  uterine and placental cells affected by DT administration in Cd11bDTR/DTR dams (Figure 
3A). Immunohistochemical analysis showed that 24 hours after DT administration, more than 95% of  
cells expressing the macrophage lineage marker F4/80 were depleted from implantation sites of  Cd11bDTR/
DTR dams (Supplemental Figure 5). Within the placental labyrinth tissue, F4/80+ cells in the intervillous 
maternal blood space were absent from Cd11bDTR/DTR dams given DT, while the majority of  F4/80+ cells 
located in the interstitial villous tissue, presumed to be fetal Hofbauer cells, were retained (Supplemental 
Figure 5). Flow cytometry analysis (Supplemental Figure 6A) showed that the number and proportion of  
macrophages (CD11b+F4/80+ cells) were reduced by more than 90% in the maternal peripheral blood, 
myometrium, and decidua 24 hours after DT administration in Cd11bDTR/DTR dams compared with control 
CD11bDTR/DTR dams given PBS or CD11bWT/WT dams given DT (Figure 3, B–D; and Supplemental Figure 6, 
B–D). Total placental macrophages were reduced by approximately 30% in cell number, whereas fetal liver 
macrophages were unchanged in Cd11bDTR/DTR dams given DT (Figure 3, E and F; and Supplemental Figure 
6, E and F). These data are consistent with loss of  Cd11bDTR/DTR maternal macrophages and retention of  
Cd11bDTR/+ fetally derived macrophages in the placenta and fetal liver.
A limitation of  the CD11bDTR/DTR model is that CD11b+ cells other than macrophages can be affect-
ed after DT administration because CD11b is expressed by some neutrophils and DCs (46). Neutrophils 
(CD11b+Ly6G+ cells) were elevated to a variable degree in the maternal peripheral blood and myometrium 
of  some Cd11bDTR/DTR dams after DT administration, but neutrophil recruitment was not evident in the 
decidua (Figure 3, G–I; and Supplemental Figure 6, G–I). In the placenta and fetal liver, neutrophils were 
not affected (Figure 3, J and K; and Supplemental Figure 6, J and K). CD11b+CD11c+ cells in the myo-
metrium and decidua were reduced by 60%–80% after DT administration in Cd11bDTR/DTR dams compared 
with control mice (Figure 3, M and N; and Supplemental Figure 6, M and N), and a reduction was also 
seen in maternal blood when considered as a proportion of  total CD45+ leukocytes (Figure 3L and Supple-
mental Figure 6L). CD11b+CD11c+ myeloid DCs were moderately depleted from the placenta when con-
sidered as a proportion of  CD45+ leukocytes, but not when absolute placental DC numbers were quantified 
(Figure 3O and Supplemental Figure 6O). Myeloid DCs were not changed in the fetal liver (Figure 3P and 
Supplemental Figure 6P).
Uterine F4/80+ macrophages and myeloid DCs exhibit a close ontogenic relationship and share phe-
notypic features (47), such that many uterine macrophages express MHC class II and have the potential 
to modulate T cell activation and phenotype (48). Many F4/80+ macrophages recovered from the myo-
metrium, decidua, and placenta on day 17 dpc also expressed MHC class II (Supplemental Figure 7), 
indicating potential to modulate T cells in late gestation. However, T cell numbers were not changed in 
the maternal blood, myometrium, or decidua (Figure 3, Q–S; and Supplemental Figure 6, Q–S), or in the 
placenta or fetal liver (Figure 3, T and U; and Supplemental Figure 6, T and U), after DT administration. 
Likewise, no changes were observed in the number or proportion of  CD4+ and CD8+ T cell subsets upon 
DT administration (Supplemental Figure 8, A–U).
Together, these findings confirmed that the acute systemic depletion of  CD11b+ cells primarily affected 
macrophages and myeloid DCs in the maternal compartment. This ablation of  CD11b+ myeloid cells was 
accompanied by functional shifts in neutrophils in the myometrium and the maternal circulation, but not 
in decidual tissue. Importantly, administration of  DT to dams did not substantially alter fetal leukocytes. 
These data support the interpretation that loss of  maternal CD11b+ myeloid cells is primarily responsible 
for preterm birth and adverse perinatal outcomes.
expressing TNF. (C) Representative FACS plots of CD45+CD14+ICAM3– cells, considered homeostatic macrophages, expressing CD206+CD209+. (D) 
Representative t-distributed stochastic neighbor embedding (t-SNE) plot of CD45+CD14+CD80+HLA-DR+ proinflammatory macrophages, color-coded 
to identify TNF+ cells from women with spontaneous preterm birth (red) and term birth (dark blue), and TNF– cells from women with spontaneous 
preterm birth (pink) and term birth (light blue). (E) Representative t-SNE plot of CD45+CD14+ICAM– homeostatic macrophages, color-coded to iden-
tify CD206+CD209+ cells from women with spontaneous preterm birth (red) and term birth (dark blue), and CD206–CD209– cells from women with 
spontaneous preterm birth (pink) and term birth (light blue). (F) Frequency of CD45+CD14+CD80+HLA-DR+ cells expressing TNF in the decidua basalis 
and decidua parietalis of women with term (n = 63–67) or spontaneous preterm (n = 23–24) birth. (G) Frequency of CD45+CD14+ICAM3– cells express-
ing CD206 and CD209 in the decidua basalis or the decidua parietalis of women with term (n = 66–68) or spontaneous preterm (n = 27–28) birth. 
Data are presented as mean and SEM. Symbols are values from individual women. Data were analyzed by Mann-Whitney U test. P values were 
considered significant when P was less than 0.05. Data on other macrophage subpopulations are shown in Supplemental Figure 2. Demographic 
and clinical characteristics of the study population are shown in Table 1.
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Figure 2. Depletion of maternal CD11b+ myeloid cells on 16 dpc induces preterm birth and adverse neonatal outcomes. (A) Cd11bDTR/DTR or Cd11bWT/WT dams 
were administered diphtheria toxin (DT, 25 ng/g, i.p.) or PBS on 16 dpc. Birth and neonatal outcomes were recorded (all n = 7–8 dams per group). Param-
eters shown are (B) rate of preterm birth (delivery within 48 hours of intervention, e.g., ≤18 dpc), analyzed by Fisher’s exact test; (C) gestational length 
presented as box plots where midlines indicate medians, boxes indicate IQR, and whiskers indicate minimum/maximum range, analyzed by Kruskal-Wal-
lis test followed by Mann-Whitney U test; and (D) Kaplan-Meier survival curves showing the percentage survival per litter of neonates at 1, 8, and 21 
days postpartum, analyzed by Mantel-Cox tests. (E–G) Violin plots showing the mean weight per litter of surviving pups at 1, 8, and 21 days postpartum. 
Symbols are median values from individual dams. Data were analyzed by 1-way ANOVA and post hoc 2-tailed t test. P values were considered significant 
when P was less than 0.05.
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Adoptive transfer of  macrophages rescues preterm birth and improves neonatal survival. To specifically address 
whether macrophages are the key lineage responsible for preterm birth after depletion of  CD11b+ myeloid 
cells from Cd11bDTR/DTR dams, we evaluated whether adoptive transfer of  WT macrophages could restore the 
timing of  parturition and prevent neonatal mortality and morbidity. WT bone marrow–derived macrophages 
(BMDMs) were generated in vitro and adoptively transferred to DT-injected Cd11bDTR/DTR dams (Figure 4A). 
As previously observed, CD11b+ myeloid cell depletion reduced the gestational length and induced preterm 
birth (Figure 4, B and C), albeit with slightly later timing due to DT administration occurring approximate-
ly 12 hours later to accommodate technical considerations. Adoptive transfer of  macrophages protected 
against preterm birth and restored gestational length, causing all dams to deliver at term (Figure 4, B and C). 
Additionally, perinatal loss was partially restored by adoptive transfer of  macrophages (Figure 4, D and E), 
but postnatal birth weight and growth impairment caused by CD11b+ myeloid cell depletion were only par-
tially improved (Figure 4, F–H). These findings showed that maternal macrophage loss was responsible for 
the adverse perinatal outcomes elicited by CD11b+ myeloid cell depletion in Cd11bDTR/DTR dams, as opposed 
to myeloid DC loss or off-target effects of  DT treatment. However, the postnatal effects of  maternal CD11b+ 
myeloid cell depletion were not fully reversed upon macrophage restoration. Thus, we investigated the mech-
anisms by which CD11b+ myeloid cell depletion caused preterm birth, then evaluated in vitro strategies to 
boost the potency of  macrophages to improve pregnancy and neonatal outcomes.
Proinflammatory mediators and leukocyte activation are implicated in preterm birth. To investigate the specif-
ic molecular and cellular changes induced by CD11b+ myeloid cell depletion, decidual tissues were col-
lected from Cd11bDTR/DTR dams 24 hours after DT administration. In an exploratory analysis, changes in 
expression of  proinflammatory mediators were evaluated in pooled tissue samples using 2 specific quanti-
tative reverse transcription PCR (RT-qPCR) arrays. The first array, targeting innate and adaptive immune 
response genes, revealed extensive (more than 8–10-fold) upregulation of  Il6 and Irf1, as well as elevated 
Cd14, Tlr9, and Il1b upon CD11b+ myeloid cell depletion (Figure 5A). STRING analysis of  these upregu-
lated mediators showed enrichment of  networks, including inflammatory response, positive regulation of  
cytokine production, and cellular response to molecule of  bacterial origin (Figure 5B). The second array, 
targeting inflammatory response and autoimmunity genes, showed more than 20-fold induction of  Cxcl3, 
as well as increased Cxcl5, Cxcl9, Cxcl10, Tnf, and Il9, upon CD11b+ myeloid cell depletion (Figure 5C). 
Enriched STRING networks for these genes were immune response, cytokine-mediated signaling pathway, 
leukocyte migration, and chemokine-mediated signaling pathway (Figure 5D).
We next evaluated expression of  the activation marker CD69 in decidual leukocytes to determine 
the impact of  maternal CD11b+ myeloid cell depletion on decidual leukocyte activation. CD69 was 
upregulated on decidual leukocytes in CD11b+ myeloid cell–depleted dams (Figure 5E), with elevated 
activation of  NK cells (Figure 5F). These analyses indicate that CD11b+ myeloid cell depletion resulted 
in upregulation of  inflammatory mediators as well as activation of  NK cells at the materno-fetal inter-
face, which are common features of  the immune changes preceding preterm birth and the accompanying 
adverse neonatal outcomes (24, 27, 49).
Progesterone rescues preterm birth but not adverse postnatal outcomes. Progesterone has potent antiinflam-
matory effects (11, 50, 51), and premature demise of  progesterone signaling can cause preterm birth (23). 
Previously, we showed that CD11b+ myeloid cell depletion from CD11bDTR/DTR mice in early pregnancy 
ablates ovarian synthesis of  progesterone within 24 hours of  DT administration (32), and others have 
shown that immune activation in early gestation elicits pregnancy loss through suppressing progester-
one synthesis (52). To determine whether CD11b+ myeloid cell depletion in late gestation might act via 
progesterone, we measured plasma progesterone concentrations in DT-injected and control Cd11bDTR/DTR 
dams. No effect of  DT administration at 16 dpc was seen on progesterone levels measured 24 hours later 
(Supplemental Figure 9A), and the precipitous decline in plasma progesterone, expected after 18 dpc in 
Figure 3. Effects of depletion of maternal CD11b+ myeloid cells on leukocyte populations in maternal and fetal tissues. (A) Cd11bDTR/DTR or Cd11bWT/WT dams 
were administered diphtheria toxin (DT, 25 ng/g, i.p.) or PBS on 16 dpc. Tissues were collected 24 hours later for analysis of leukocytes by flow cytometry 
with markers CD45, CD11b, F4/80, Ly6G, CD11c, CD3, CD4, and CD8, according to the gating strategy in Supplemental Figure 6, to quantify (B–F) macro-
phages, (G–K) neutrophils, (L–P) DCs, and (Q–U) T cells in the maternal peripheral blood, uterine myometrium, uterine decidua, placenta, and fetal liver (n = 
8–9 per group). Data are presented as box plots where the midline indicates the median, the box indicates IQR, and whiskers indicate the minimum/maxi-
mum range. Symbols are values from individual dams. Data were analyzed by 1-way ANOVA and post hoc 2-tailed t test. P values were considered significant 
when P was less than 0.05. Data on macrophages, neutrophils, DCs, and T cells as a proportion of total CD45+ cells are shown in Supplemental Figure 6. Data 
on CD4+ and CD8+ T cell subsets are shown in Supplemental Figure 8.
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Figure 4. Adoptive transfer of macrophages prevents preterm birth but does not restore adverse neonatal outcomes after depletion of maternal CD11b+ 
myeloid cells. (A) Bone marrow cells were collected from Cd11bWT/WT mice and differentiated into nonpolarized macrophages (Mϕ) by in vitro culture in 
complete RPMI medium. Nonpolarized macrophages or vehicle were adoptively i.v. transferred to Cd11bDTR/DTR dams on 14.5 dpc and 16.5 dpc, followed 
by diphtheria toxin administration (DT, 25 ng/g, i.p.) on 16.5 dpc. Control Cd11bWT/WT females were administered vehicle and DT (25 ng/g, i.p.). Birth and 
neonatal outcomes were recorded (all n = 11–21 dams per group). Parameters shown are (B) rate of preterm birth (delivery within 48 hours of intervention, 
e.g., ≤18.5 dpc), analyzed by Fisher’s exact test; (C) gestational lengths presented as box plots where midlines indicate medians, boxes indicate IQR, and 
whiskers indicate minimum/maximum range, analyzed by 1-way ANOVA and post hoc 2-tailed t test; (D) neonatal mortality per litter of pups, analyzed by 
Mann-Whitney U tests; and (E) Kaplan-Meier survival curves showing the percentage of survival per litter from day 1 until day 21 after birth of neonates, 
analyzed by Mantel-Cox test. (F–H) Violin plots (medians) showing the mean weight per litter of neonates at 1, 8, and 21 days postpartum. Symbols are 
median values from individual dams. Data were analyzed by 1-way ANOVA and post hoc 2-tailed t test.
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Figure 5. Depletion of maternal CD11b+ myeloid cells promotes upregulation of inflammatory mediators and leukocyte activation at the materno-fe-
tal interface. Cd11bDTR/DTR dams were administered diphtheria toxin (DT, 25 ng/g, i.p.) or PBS on 16 dpc. The uterine decidua was collected 24 hours later 
for gene expression profiling using RT-qPCR arrays (tissue pooled from n = 7–8 per group) and for analysis of leukocytes by flow cytometry (n = 7–8 per 
group). (A) Heatmap of differentially expressed genes and (B) interaction network obtained by STRING analysis of pathways attenuated in the decidua 
1 1
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WT mice (53), did not occur prematurely after CD11b+ myeloid cell depletion. Nevertheless, given that 
progesterone can mitigate LPS-induced preterm birth in mice (54) and is an effective clinical intervention 
for some women at risk of  preterm birth (55), we tested whether exogenous progesterone might alleviate 
the adverse pregnancy outcomes in CD11b+ myeloid cell–depleted dams (Supplemental Figure 9B). Pro-
gesterone protected Cd11bDTR/DTR dams from preterm birth caused by CD11b+ myeloid cell depletion and 
extended gestational length (Supplemental Figure 9, C and D). However, progesterone did not improve 
the survival of  neonates born to CD11b+ myeloid cell–depleted dams (Supplemental Figure 9E) or atten-
uate growth impairment in surviving neonates (Supplemental Figure 9, F–H). These results showed that 
although progesterone supplementation can help sustain uterine quiescence caused by depletion of  mater-
nal CD11b+ myeloid cells, it is not adequate to overcome the adverse neonatal effects, implying a mecha-
nism of  macrophage action that is independent of  progesterone.
Adoptive transfer of  in vitro M2-polarized macrophages prevents intra-amniotic inflammation–induced preterm 
birth and reduces neonatal mortality. The findings in the Cd11bDTR/DTR model implicated macrophages as exert-
ing an antiinflammatory/homeostatic role in order to sustain uterine quiescence. This is consistent with 
the finding that decidual macrophages displaying markers of  alternative activation (i.e., an M2 phenotype) 
were enriched in women who delivered a healthy term neonate (Figure 1G). Therefore, we investigated 
whether in mice, macrophages at the materno-fetal interface also exhibit an antiinflammatory profile during 
late gestation. Macrophages were recovered from the uterine decidua and myometrium by cell sorting from 
WT mice, and their cytokine synthesis was evaluated (Supplemental Figure 10A). Decidual macrophages 
released high levels of  antiinflammatory cytokines TGF-β and IL-10, the latter increasing as gestation 
progressed (Supplemental Figure 10B), accompanied by reduced proinflammatory IL-12 between 17.5 dpc 
and term (Supplemental Figure 10C). Myometrial macrophages displayed a similar cytokine profile (Sup-
plemental Figure 10, D and E). Since IL-10 and IL-12 are antagonistically opposing and an elevated IL-10 
to IL-12 ratio is an indicator of  homeostatic M2 function (56, 57), this implies that decidual macrophages 
have antiinflammatory functions during late gestation.
Next, we investigated whether macrophages polarized in vitro toward an M2 phenotype could 
protect against inflammation-induced preterm birth and adverse neonatal outcomes. We utilized a 
model of  intra-amniotic inflammation and reasoned that treatment of  macrophages to induce polar-
ization toward an M2 antiinflammatory phenotype would maximize their effectiveness after transfer. 
The ability of  IL-4 plus IL-13 to differentiate and polarize BMDMs to M2 macrophages in vitro was 
confirmed by their expression of  the markers Egr-2 (58) and Ym1/2 (59) (Figure 6A). BMDMs with-
out polarization were included to investigate the relative efficacy of  M2-polarized versus nonpolarized 
macrophages. Macrophages were adoptively transferred to dams that received an ultrasound-guided 
intra-amniotic injection of  LPS, an intervention that resembles the clinical scenario of  intra-amniotic 
inflammation (45, 60, 61) (Figure 6B). Intra-amniotic inflammation caused preterm birth in 80% of  
dams. This rate decreased to 27% after adoptive transfer of  M2-polarized macrophages but was not 
improved by nonpolarized BMDMs (Figure 6C). The reduced gestational length (Figure 6D) and ele-
vated neonatal mortality (Figure 6E) elicited by LPS were also restored by transfer of  M2-polarized 
macrophages but not BMDMs. Using GFP+ transgenic mice, we showed that transferred macrophages 
infiltrated the myometrial, decidual, and placental tissues (Figure 6F), although the number of  cells 
recovered was at least an order of  magnitude lower than seen in WT control mice, indicating that only 
partial macrophage replacement was achieved. Nevertheless, transfer of  macrophages polarized in vitro 
toward an antiinflammatory M2 phenotype was surprisingly effective in protecting pregnancy and neo-
natal outcomes, to a substantially greater extent than was achieved with nonpolarized macrophages.
Adoptive transfer of  in vitro M2-polarized macrophages reduces maternal and intra-amniotic inflammatory medi-
ators as well as fetal tissue inflammation. We next explored the mechanisms by which in vitro M2-polarized 
macrophages exert protection from preterm birth and neonatal loss. Maternal serum and amniotic fluid 
after depletion of CD11b+ cells, obtained using the “innate and adaptive immune response” array. (C) Heatmap of differentially expressed genes and (D) 
interaction network obtained by STRING analysis of pathways attenuated in the decidua after depletion of CD11b+ cells, obtained using the “inflammato-
ry response and autoimmunity” array. Flow cytometry gating strategy for determining the effect of CD11b+ cell depletion on proportions of (E) activated 
leukocytes (CD69+/CD45+ cells) and (F) NK cells (CD49b+CD69+/CD45+ cells) in decidual tissues. Data are presented as box plots where the midline indicates 
the median, the box indicates the IQR, and whiskers indicate the minimum/maximum range. Symbols are values from individual dams. Data were ana-
lyzed by Mann-Whitney U tests. P values were considered significant when P was less than 0.05.
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were obtained from dams administered intra-amniotic LPS with or without adoptive transfer of  in vitro 
M2-polarized macrophages to quantify proinflammatory and antiinflammatory mediators (Figure 7A). 
Transfer of  M2-polarized macrophages modulated the LPS-mediated induction of  proinflammatory cyto-
kines and chemokines in maternal blood, with reduced CCL2, CCL4, CXCL2, CXCL10, IL-5, IFN-γ, 
and G-CSF, as well as increased IL-10 (Figure 7, B–I). Transfer of  M2-polarized macrophages also had 
antiinflammatory effects in the amniotic cavity, indicated by reduced CXCL10 and a tendency (although 
nonsignificant) toward increased IL-10 (Figure 7, J and K).
We also measured the expression of  proinflammatory and antiinflammatory mediators in fetuses of  
dams that received intra-amniotic LPS with or without adoptive transfer of  in vitro M2-polarized mac-
rophages (Figure 8A). Proinflammatory gene expression was reduced in the fetal brain after transfer of  
M2-polarized macrophages (Figure 8B). Downregulated genes included proinflammatory mediators (Il6, 
Tnf, Il1b, Il1a, Il2, Il3, Il23), chemokines (Ccl2, Ccl3, Ccl22), inflammasome-related mediators (Nod1, Nod2, 
Casp1, Nlrc4, Aim2, Nlrp1a, Casp11), and cell adhesion molecules (Sele, Sell, Vcam1), while Ccl5 was upreg-
ulated (Figure 8C and Supplemental Figure 11A). Similar changes were observed in the fetal lung (Figure 
8D), where expression of  the inflammatory mediators Il6, Il5, Ccl2, Casp1, Nod1, Casp11, Nlrc4, and Aim2 
decreased after transfer of  M2-polarized macrophages (Figure 8E and Supplemental Figure 11B). In con-
trast, expression of  Il33 was increased in the fetal lung after transfer of  M2-polarized macrophages (Figure 
8E). In both the fetal brain and lung, Il10 expression tended to increase but did not reach statistical signifi-
cance (Figure 8, C and E).
Taken together, these findings demonstrated that M2-polarized macrophages can prevent intra-amniot-
ic inflammation–induced preterm birth and adverse neonatal outcomes by reducing inflammatory respons-
es in the maternal circulation, the amniotic cavity, and the fetal tissue.
Discussion
Here, we report that women with spontaneous preterm birth exhibited a shift in the activation status of  
macrophages in the uterine decidua, with a reduced proportion of  macrophages expressing markers of  
alternative activation. This suggested that macrophages might help sustain pregnancy, contrary to the 
common assumption that macrophages accelerate parturition. In support of  a beneficial role, depletion of  
maternal CD11b+ myeloid cells from mice led to preterm birth and adverse neonatal outcomes. Depletion 
caused elevated proinflammatory mediators and increased activated leukocytes in the decidua, as well as 
increased neutrophils in the myometrium. Adoptive transfer of  in vitro M2-polarized macrophages reduced 
preterm birth and improved neonatal survival in a model of  intra-amniotic inflammation more effectively 
than nonpolarized macrophages. M2-polarized macrophages reduced proinflammatory mediators in the 
maternal blood and amniotic cavity and downregulated inflammatory gene expression in the fetal brain 
and lung. These data provide strong evidence that macrophages with antiinflammatory and homeostatic 
functions act to sustain uterine quiescence and fetal integrity in late gestation.
Our findings build on prior studies implicating homeostatic macrophages in fetal tolerance during early 
pregnancy (35, 36, 38, 62) and midgestation (34, 63) and expand on a report that systemic macrophage 
depletion from mice on 15 dpc caused fetal morbidity and mortality (28). However, earlier studies have not 
reported preterm birth or perinatal loss after macrophage depletion, suggesting the physiological roles of  
uterine macrophages depend on the gestational stage.
We found depletion of  CD11b+ cells resulted in extensive loss of  CD11b+F4/80+ cells but also caused 
a reduction in CD11b+CD11c+ myeloid DCs, as occurs when macrophages are depleted from Cd11bDTR/DTR 
Figure 6. Adoptive transfer of M2-polarized macrophages prevents intra-amniotic inflammation–induced preterm birth and adverse neonatal 
outcomes. (A) Bone marrow–derived cells collected from C57BL/6 mice were differentiated into macrophages by in vitro culture with M-CSF followed by 
stimulation with IL-4 and IL-13 to induce M2 polarization. M2 polarization was confirmed by macrophage expression of Egr-2 and Ym1/2 analyzed by flow 
cytometry. Unpolarized bone marrow–derived macrophages (BMDMs) were also utilized. (B) M2-polarized macrophages (M2 Mϕ), BMDMs, or vehicle were 
i.v. administered on 15.5 dpc and 16.5 dpc to C57BL/6 dams followed by intra-amniotic injection with LPS or PBS on 16.5 dpc. Pregnancy and neonatal out-
comes were recorded (n = 6–10 dams per group). Parameters shown are (C) rate of preterm birth (delivery within 48 hours of intervention, e.g., <18.5 dpc), 
analyzed by 1-tailed Fisher’s exact tests; (D) gestational length, presented as box plots where midlines indicate medians, boxes indicate IQR, and whiskers 
indicate minimum/maximum range, analyzed by Mann-Whitney U tests, and (E) neonatal mortality of pups per litter, analyzed by Mann-Whitney U 
tests. (F) Study design to detect GFP+ M2-polarized macrophages in maternal and fetal tissues. Bar plots representing the median numbers of adoptively 
transferred GFP+ M2-polarized macrophages in the myometrium, decidua, and placenta of recipient dams after intra-amniotic injection with LPS (n = 5). 
Symbols are values from individual dams. P values were considered significant when P was less than 0.05.
1 4
R E S E A R C H  A R T I C L E
JCI Insight 2021;6(19):e146089  https://doi.org/10.1172/jci.insight.146089
Figure 7. Adoptive transfer of M2-polarized macrophages to dams reduces inflammatory cytokines in maternal 
peripheral blood and fetal amniotic fluid. (A) M2-polarized macrophages (M2 Mɸ) or vehicle were i.v. administered 
on 15.5 dpc and 16.5 dpc to C57BL/6 dams followed by intra-amniotic injection with LPS on 16.5 dpc (M2+LPS). Control 
C57BL/6 dams were injected intra-amniotically with LPS only (LPS). Dams were euthanized 16 hours after LPS injection 
to collect maternal plasma and fetal amniotic fluid. Multiplex bead assays were used to determine the concentrations 
of CCL2 (B), CCL4 (C), CXCL2 (D), CXCL10 (E), IL-5 (F), IFN-γ (G), G-CSF (H), and IL-10 (I) in plasma (n = 10 dams per group) 
and concentrations of CXCL10 (J) and IL-10 (K) in amniotic fluid (n = 5–8 each). Data are presented as box plots where 
midlines indicate medians, boxes indicate IQR, and whiskers indicate minimum/maximum range. Symbols are values 
from individual dams and fetuses. Data were analyzed by Mann-Whitney U tests.
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mice in early gestation (64). Uterine macrophages and DCs have a close ontogenic relationship (47), share 
phenotypic characteristics (65), and operate within the broader context of  innate and adaptive immune net-
works in the uterus and placenta (66–68). Activated T cells are implicated in the causal pathways accelerat-
ing preterm birth (61, 69, 70), and there is clear potential for myeloid DCs to attenuate T cell activation and 
phenotype in late gestation (27, 69). DCs with a regulatory phenotype are present in gestational tissues from 
implantation and are thought to promote materno-fetal tolerance by virtue of  their eliciting type 2 T helper 
and Treg cell responses (71, 72). A shift away from this tolerogenic state occurs in decidual DCs near term, 
implying a role in the accompanying T cell changes (69). On the other hand, maintenance of  a low decid-
ual DC population may be critical for minimizing T cell priming to fetal antigens and the effector activity 
of  sporadic infiltrating T cells (47). Considering the potential for DCs and macrophages to regulate T cell 
phenotypes, it was possible that CD11b+ cell depletion would result in expanded effector T cell populations 
that in turn could mediate fetal damage. However, we did not identify any change in the total number of  
decidual CD4+ or CD8+ T cells after CD11b+ cell depletion. Nevertheless, we cannot exclude a possible 
contribution of  myeloid DCs to the causal events of  preterm birth after DT administration in Cd11bDTR/DTR 
mice, for example, through attenuating the balance of  T cell regulatory or inflammatory phenotypes.
CD11b+ myeloid cell depletion also induced elevated circulating neutrophils as well as neutrophil influx 
into the uterine myometrium. Previous studies in CD11bDTR/DTR mice show macrophage loss promotes gran-
ulopoiesis (73, 74), secondary to clearance of  apoptotic neutrophils (75). Neutrophil recruitment is a con-
sistent precursor of  uterine activation, myometrial contractility, and preterm birth (22, 23). Previous reports 
show that women who undergo spontaneous preterm birth have higher circulating neutrophils than women 
with iatrogenic preterm birth (76). Limiting neutrophil influx into myometrial tissues during late gestation 
could thus be one mechanism by which homeostatic macrophages assist in maintaining uterine quiescence.
CD11b+ cell depletion substantially increased expression of  inflammatory mediators in decidual tissues 
and caused activation of  resident leukocytes, particularly NK cells. NK cells are abundant in the mater-
no-fetal interface in the third trimester (77), and their increased activation is associated with preterm birth 
(78, 79). M2 macrophages are a rich source of  IL-10 (30) and potentially suppress uterine NK cells through 
IL-10 release (80), as demonstrated by studies in Il10-null mutant mice, which exhibit heightened suscep-
tibility to preterm birth associated with uterine NK cell activation (49, 81). A regulatory effect of  macro-
phages on uterine NK cells in late gestation is in line with several studies demonstrating that uterine NK 
cell activation, and other perturbations to pregnancy tolerance, lead to preterm birth and adverse neonatal 
outcomes (24, 27, 49). Decidual stromal cells undergo epigenetic modification to prevent certain effector 
immune cells from accessing the placental interface, and this is reversed in response to proinflammatory 
stimuli (82, 83). We speculate that homeostatic macrophages might contribute to enforcing this epigenetic 
state, but this remains to be investigated.
Finding suitable therapies for the prevention or treatment of  spontaneous preterm birth remains a major 
clinical challenge (13, 84, 85). Currently, the only effective intervention is administration of  vaginal progester-
one to women with a short cervix (55). Progesterone is believed to prolong uterine quiescence through potent 
antiinflammatory effects (51). In the current study, progesterone effectively suppressed uterine activation but 
not fetal inflammatory injury. This may be due to the vulnerability of  developing fetal tissues to inflammatory 
mediators (15) and/or their limited capacity for progesterone signaling (50). Given that plasma progester-
one was not affected by macrophage depletion, these data indicate that macrophages sustain late gestation 
through a mechanism other than via modulating progesterone synthesis, in contrast to a model of  midgesta-
tion pregnancy loss induced by activation of  the innate immune system (52).
To understand how macrophages suppress preterm birth and alleviate adverse perinatal outcomes, we 
first tested whether adoptive transfer of  nonpolarized macrophages could mitigate the detrimental effects 
seen after depletion. Restoration of  macrophages extended gestation length, prevented preterm birth, and 
Figure 8. Adoptive transfer of M2-polarized macrophages to dams reduces inflammatory gene expression in fetal brain and lung after intra-amniotic 
administration of LPS. (A) M2-polarized macrophages (M2 Mɸ) or vehicle were i.v. administered on 15.5 dpc and 16.5 dpc to C57BL/6 dams followed by 
intra-amniotic injection with LPS on 16.5 dpc (M2+LPS). Control C57BL/6 dams were injected intra-amniotically with LPS only (LPS). Dams were eutha-
nized 16 hours after LPS injection to collect fetal brain and lung for evaluation of gene expression. (B) Heatmap visualization of inflammatory gene expres-
sion in fetal brains from M2+LPS and LPS dams (n = 8–10 each). (C) Expression of Il6, Tnf, Il1b, Il10, Ccl2, Ccl3, Ccl5, Ccl22, Nod1, Nod2, Casp1, and Nlrc4 in 
fetal brains. (D) Heatmap visualization of inflammatory gene expression in fetal lungs from M2+LPS and LPS dams (n = 8–21 each). (E) Expression of Il6, 
Il33, Ccl2, Il10, Casp1, Nod1, Nod2, and Nlrc4 in fetal lungs. Data are presented as box plots with medians, IQRs, and minimum/maximum ranges. Symbols 
are values from individual fetuses. Data were analyzed by Mann-Whitney U tests. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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improved neonatal survival and postnatal growth impairment. This showed that macrophages are primarily 
responsible for the adverse outcomes elicited by CD11b+ cell depletion in CD11bDTR/DTR mice and con-
firmed their significance in protecting late gestation, but raised the question of  whether the phenotype of  
macrophages is critical. We observed that, as gestation progressed, decidual macrophages released increas-
ing IL-10 (a hallmark antiinflammatory product of  M2 macrophages and inhibitor of  proinflammatory 
IL-12 secretion) (56, 57), consistent with prior demonstrations that M2 macrophages in the uterine decidua 
produce IL-10 (18, 35). An exploratory experiment showed strongly elevated decidual Il6, Irf1, and Cxcl3 
expression after macrophage depletion. These results pointed to M2-like activity in uterine macrophages 
in late gestation, as occurs earlier in pregnancy (35). The efficacy of  unpolarized and in vitro M2-polarized 
macrophages was then directly compared in a model of  intra-amniotic LPS–induced preterm birth (45, 60), 
which more closely reflects the human pathophysiology of  premature labor. Consistent with our hypothe-
sis, M2-polarized macrophages demonstrated superior protective activity over nonpolarized macrophages, 
with only M2 macrophages effective in reducing the incidence of  preterm birth and neonatal mortality 
induced by intra-amniotic LPS.
The reason that unpolarized macrophages were effective in the Cd11bDTR/DTR model but not the intra-am-
niotic LPS model most likely relates to the proinflammatory insult of  LPS. Presumably, M2 macrophages 
were more potent suppressors of  inflammation than BMDMs by virtue of  their phenotype being further 
skewed and more stably embedded. In another study, macrophage depletion using anti-F4/80 antibody 
suppressed preterm birth caused by intravaginal LPS (54), implying that insufficiently stable homeostatic 
macrophages can convert to proinflammatory effector activity in response to elevated TLR signaling. M2 
macrophages generated in vitro may be better able to retain and express an antiinflammatory effector func-
tion and be less responsive to local cues than unpolarized BMDMs.
We and others have shown that biologic drugs targeting inflammatory cytokines can prevent preterm 
birth and adverse neonatal outcomes by dampening systemic and local inflammatory responses (44, 45, 
86–88). Consistent with a similar action, we showed that M2-polarized macrophages infiltrated the mater-
no-fetal interfaces after transfer and modulated cytokine production locally in gestational tissues, as reflect-
ed in the amniotic cavity, as well as systemically in the maternal peripheral blood. Importantly, the trans-
ferred M2-polarized macrophages reduced fetal inflammatory responses induced by LPS in the fetal brain 
and lungs, indicating that this cellular approach is active in the fetal compartment and has comparable 
efficacy to other antiinflammatory interventions that alleviate fetal inflammation (45, 87, 88). However, 
M2 macrophages were not 100% effective in rescuing neonates born to LPS-treated dams and some did not 
survive. This was most likely due to less-than-complete macrophage reconstitution, given the technical lim-
itation on delivering sufficient cells to fully recapitulate the steady-state condition, and evidence that uterine 
and placental cells were not fully reconstituted by adoptive transfer. These data imply that the late-gestation 
fetus is highly dependent on maternal homeostatic macrophages for protection from inflammatory injury, 
to a greater degree than the quiescent uterus. Consistent with this, fetal inflammatory injury has previously 
been demonstrated under conditions of  mild uterine inflammation that are insufficient to cause preterm 
birth (88, 89). The rapidly developing fetal brain, lung, and gastrointestinal tract are thought to be highly 
vulnerable to effects of  inflammatory mediators that can program permanent structural changes (14, 15).
We found M2 macrophages attenuated fetal brain and lung expression of  inflammasome components, 
resonating with an emerging role for inflammasome assembly in gestational disorders and fetal tissue injury 
(12, 90, 91). A feature of  treatment with M2-polarized macrophages was upregulated expression of  IL-33 in 
the fetal lung. This cytokine is a crucial immune modulator that shapes type 1, type 2, and regulatory immune 
responses (92). The maternal and/or fetal tissue compartment in which passively transferred macrophages act 
to attenuate fetal cytokine expression is unclear. A high abundance of  transferred cells in the placenta implies 
a function in suppressing fetal proinflammatory activation through direct or indirect effects on the placental 
immune network. Here, maternal macrophages could suppress placental inflammatory injury and limit pla-
cental transfer of  inflammatory mediators (15). This likely reflects accumulation of  transferred macrophages 
in maternal blood spaces, which seems more probable than migration across the trophoblast barrier into pla-
cental villous tissue or the fetus itself. However, further investigation of  the site of  action is required, as fetal 
trafficking of  maternal cells is reported to occur (93), and maternal bone marrow–derived mesenchymal stem 
cells are thought to alleviate perinatal inflammatory injury to the fetal brain by this route (94).
These findings provide solid evidence that maternal macrophages exert homeostatic effects on 
maternal and fetal tissues during late gestation and that, in the event of  deficiency, their restoration 
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can be an effective strategy to dampen maternal and fetal inflammation. The feasibility of  targeting M2 
macrophages for clinical benefit in pregnant women at risk of  preterm birth and/or fetal inflammatory 
injury therefore warrants consideration — especially as our data imply that macrophage therapies have 
potential for clinical effects distinct from those of  progesterone, the most effective existing therapy for 
women at risk of  preterm labor (95). M2-polarized macrophages generated in vitro have been investi-
gated for therapeutic applications in cancer, and clinical efficacy with minimal side effects was report-
ed (96). A recent clinical trial reported significant neurological improvement after intrathecal transfer 
of  M2-polarized autologous macrophages to stroke patients (97). These investigations provide a ratio-
nale for considering adoptive transfer of  autologous M2-polarized macrophages in appropriately select-
ed pregnant women at risk for delivering preterm. Whether this approach is appropriate for protection 
against the range of  inflammatory stimuli implicated in spontaneous preterm birth, including sterile as 
well as microbial agents (5–7), will be important to consider.
Future research is required to define the specific mechanisms whereby homeostatic macrophages 
regulate susceptibility to uterine and fetal inflammation. In particular, given the significance of  fetal 
immune activation in triggering premature labor (70, 98, 99), it will be critical to define whether insuf-
ficiency or instability in maternal homeostatic macrophages contributes to initiating fetal and placental 
immune activation, as would be predicted in line with a paramount role for maternal regulation of  
inflammatory cues in preterm labor (100).
In conclusion, this study provides descriptive and mechanistic evidence that macrophages play a cen-
tral homeostatic role in pregnancy maintenance in late gestation. The requirement for macrophages to 
exert protective, antiinflammatory functions in late gestation is reminiscent of  homeostatic actions in other 
tissue settings (29, 30). Collectively, the findings reported in this study support the evaluation of  M2-po-
larized macrophages as a therapeutic target in women with threatened spontaneous preterm birth and to 
protect infants from poor neonatal outcomes caused by inflammatory exposures in utero.
Methods
Human tissue and decidual leukocyte analysis. Human decidual tissue samples were collected at Hutzel Wom-
en’s Hospital in the Detroit Medical Center, Detroit, Michigan, USA, from women with spontaneous 
preterm birth, iatrogenic preterm birth, or term delivery (demographic and clinical characteristics shown in 
Table 1 and Supplemental Table 1). Leukocytes were isolated from decidual tissues of  each study group by 
using a Miltenyi Biotec gentleMACS Dissociator followed by flow cytometry analysis. Further details are 
provided in Supplemental Methods.
Mice and experimental treatments. Female Cd11bDTR/DTR mice (Tg[ITGAM-DTR/EGFP]34Lan, provided 
by Richard Lang, University of  Cincinnati, Cincinnati, Ohio, USA) (43) and Cd11bWT/WT (WT FVB/N) 
were mated with BALB/c males (both Animal Resources Centre, Canning Vale, Western Australia, Austra-
lia), and the presence of  a vaginal plug indicated 0.5 dpc. Cd11bDTR/DTR dams were administered 25 ng/g of  
DT on 16 dpc or 17 dpc to deplete CD11b+ cells. Control Cd11bDTR/DTR dams were given 200 μL PBS, and 
Cd11bWT/WT dams were given 25 ng/g DT. Some Cd11bDTR/DTR and Cd11bWT/WT dams also received proges-
terone or BMDMs. C57BL/6 dams received an ultrasound-guided intra-amniotic injection of  100 ng LPS. 
After treatments, dams were monitored to identify delivery time or euthanized for tissue recovery. Preterm 
birth was defined as delivery within 48 hours of  intervention, and the rate was calculated as the proportion 
of  the total number of  pregnant mice. Pup survival and weight were evaluated at birth, at 12–24 hours after 
birth, and at 8 and 21 days of  age. Further details are provided in Supplemental Methods.
Isolation, differentiation, and adoptive transfer of  BMDMs. Bone marrow from Cd11bWT/WT mice was 
incubated in media supplemented with 20% L929 conditioned media as described (32). C57BL/6 bone 
marrow cells were incubated with 10 ng/mL of  recombinant CSF-1 (BioLegend, 576402) for 7 days, 
then with 10 ng/mL each of  recombinant IL-4 (BioLegend, 574302) and IL-13 (BioLegend, 575902) 
(M2-polarized macrophages), or fresh IMDM plus 10% FBS and 10 ng/mL CSF1 (unpolarized mac-
rophages), for 2 days. Some mice were administered GFP+ M2-polarized BMDMs from C57BL/6-Tg(-
CAG-EGFP)131Osb/LeySop mice to allow tracking of  passively transferred macrophages recruited 
into gestational tissues. Further details are provided in Supplemental Methods.
Immunohistochemistry and immunophenotyping of  murine leukocytes. Whole uterus (myometrium and 
endometrium) and placenta were collected from Cd11bDTR/DTR dams 24 hours after administration of  DT 
or PBS on 16 dpc, and macrophages were detected with rat anti–mouse F4/80 by immunohistochemistry. 
1 9
R E S E A R C H  A R T I C L E
JCI Insight 2021;6(19):e146089  https://doi.org/10.1172/jci.insight.146089
Single-cell suspensions were prepared from the uterine myometrium, uterine decidua, placenta, and fetal 
liver, as previously described (101), from Cd11bDTR/DTR or Cd11bWT/WT dams 24 hours after administration 
of  DT or PBS on 16 dpc, and leukocytes were analyzed by flow cytometry. Further details are provided in 
Supplemental Methods.
Quantification of  progesterone, cytokine secretion by myometrial/decidual macrophages, cytokine concen-
trations in maternal plasma and amniotic fluid, and gene expression. Peripheral blood plasma progesterone 
was measured by using an enzyme-linked immunoassay (Mouse/Rat Progesterone Kit, ALPCO Diag-
nostics, 55-PROMS-E01), following the manufacturer’s instructions. Supernatants from myometri-
al and decidual tissue macrophages, sorted by positive selection of  F4/80+ cells, were analyzed for 
IL-10, IL-12p70, TNF, and TGF-β concentrations by using Quantikine ELISA Kits (R&D Systems, 
Bio-Techne). Maternal plasma and amniotic fluid cytokines were measured by using the ProcartaPlex 
Mouse Cytokine & Chemokine Panel 1A 36-plex (Invitrogen, Thermo Fisher Scientific) and Luminex 
100 SystemFill. cDNA from decidual tissue collected 24 hours after intervention was analyzed by using 
QIAGEN RT² Profiler Mouse Innate & Adaptive Immune Response and RT² Profiler Mouse Inflamma-
tory Response & Autoimmunity PCR arrays (Supplemental Table 4). Interaction network analysis was 
performed by using STRING v.10.0 software (102). Fetal brain and lung cDNA were analyzed by Flu-
idigm BioMark System for high-throughput RT-qPCR with TaqMan gene expression assays (Applied 
Biosystems, Thermo Fisher Scientific; Supplemental Table 5). Further details are provided in Supple-
mental Methods.
Statistics. Statistical analyses were performed by using SPSS v19.0 (IBM) and Prism v8.3.0 (GraphPad). 
For human demographic data, the group comparisons were performed by using the Mann-Whitney U test 
for continuous variables, Fisher’s exact test for binary nominal variables, and χ2 test for categorical nom-
inal variables. For mouse data, Fisher’s exact test was performed to evaluate preterm birth rate and other 
categorical data, and Kaplan-Meier survival curves were used to plot and compare neonatal survival data 
(Mantel-Cox test). A Shapiro-Wilk test was performed to determine whether data were normally distribut-
ed. Comparisons among multiple groups were performed by using 1-way ANOVA and a post hoc 2-tailed 
t test, by using the 2-stage linear step-up procedure of  Benjamini, Krieger, and Yekutieli to correct for mul-
tiple comparisons in normally distributed data sets, or the Kruskal-Wallis test followed by Mann-Whitney 
U test for non-normally distributed data sets. For RT-qPCR arrays, the –ΔCt values were normalized by 
calculating the z score of  each gene, and then heatmaps were created to represent the mean of  the z score 
of  –ΔCt and hierarchical clustering by using Euclidian distance. P values were considered significant when 
P was less than 0.05.
Study approval. The collection and utilization of  human biological materials for research purposes were 
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